Deep Tech Startups

Vaire develops reversible computing hardware to improve energy efficiency and compute performance beyond the constraints of Moore's law. The company targets machine intelligence applications in AI and defense sectors.

6 investors

Visionary Machines develops passive optical sensing systems that produce real-time, georeferenced 3D representations of the environment across multiple spectral bands, including in GPS-denied conditions. Its technology serves defence, government, and commercial sectors for applications such as counter-drone detection, off-road autonomous navigation, and surveillance and reconnaissance.

6 investors

Waypoint Bio uses artificial intelligence, computer vision, and pooled screening to conduct deep phenotyping across thousands of cell therapy designs, enabling the discovery and optimization of superior cell therapy candidates for development.

6 investors

Windfall Bio develops microbial-based solutions that convert methane into valuable products for industrial and agricultural customers. The company uses naturally occurring microorganisms to enable commercial-scale methane mitigation across industries.

6 investors

X-energy develops advanced nuclear energy technology, including small modular high-temperature gas reactors and TRISO fuel. Its reactors are designed to supply electricity and high-temperature steam for utilities and energy-intensive heavy industry.

6 investors

Zafrens develops a unified drug discovery platform that integrates isolation, imaging, and sequencing workflows to accelerate the identification of therapeutic compounds across modalities. The platform leverages AI and high-resolution data to compress timelines in drug development.

6 investors

Zama provides a protocol that encrypts transaction amounts, balances, and commercial references on public blockchains while keeping addresses public, enabling confidential onchain corporate payments such as cross-border vendor settlement, marketplace payouts, and treasury flows. It targets financial institutions and enterprises, integrating with existing custody, treasury, ERP, and compliance systems while running in production on Ethereum mainnet.

6 investors

ZETA Surgical makes a cranial navigation system for neurosurgical procedures including ventriculostomy, brain biopsy, and transcranial magnetic stimulation in operating rooms and interventional suites. The company serves neurosurgeons and healthcare systems.

6 investors

Axelspace manufactures microsatellites using onsite cleanroom facilities and develops commercial applications for satellite technology. The company serves the space industry and related sectors requiring Earth observation and communications capabilities.

6 investors

Synspective develops SAR (synthetic aperture radar) satellite solutions and geospatial data services for government and commercial clients, with applications in disaster management, environmental monitoring, and national security. The company operates globally through regional teams across Japan, Singapore, the United States, Europe, and Latin America.

6 investors

STRM.BIO develops a gene therapy delivery platform based on megakaryocyte-derived extracellular vesicles (STRM MVs) that target and deliver genetic cargoes preferentially to bone marrow and hematopoietic stem cells. The platform enables in vivo genetic medicines with an initial focus on rare hematological diseases and CAR-T therapies, supporting approaches such as gene editing, RNA therapeutics, and immune cell engineering.

5 investors

64x develops infrastructure and manufacturing systems for next-generation medicines, focusing on genetic engineering, cell line development, and computational biology to enable scalability of advanced therapies.

5 investors

A-Alpha Bio uses synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions for pharmaceutical discovery and development. The company operates experimental (AlphaSeq) and computational (AlphaBind) platforms to accelerate the design of novel therapeutics.

5 investors

Absci uses an AI-based drug creation platform combined with wet lab validation to design biologic therapeutics such as antibodies from scratch. It develops drug candidates like ABS-201 for conditions including androgenetic alopecia and applies reverse immunology for novel target discovery.

5 investors

Adaptyv Bio develops technologies for protein engineering that enable the design and testing of new proteins for applications in medicine, industrial enzymes, and functional materials. The company serves protein engineers and researchers developing therapeutic and industrial biological products.

5 investors

Addis Energy develops technology that combines oil and gas engineering expertise with advanced research to access energy and resources from subsurface geology.

5 investors

Adimab operates a yeast-based antibody discovery and engineering platform that produces fully human antibodies, heavy-chain antibodies, and multispecifics (including T-cell engagers) for biopharma partners. It offers services from antigen acquisition through preclinical lead generation, including AI-guided protein engineering, and works with partners through discovery, platform licensing, and technology-module collaboration models.

5 investors

Aera Therapeutics develops genetic medicines using next-generation delivery technologies and precision payloads optimized for specific diseases. The company focuses on advancing transformative treatments in areas including oncology, rare genetic diseases, and cell therapies.

5 investors

Forerunner is a website template and creative engine designed for brands and creators to build portfolios, agency sites, and project launches with polished design systems and flexible components.

5 investors

AheadComputing develops high-performance 64-bit RISC-V application processor cores designed to maximize per-core CPU performance for AI, cloud, client, mobile, and edge workloads. Founded by former Intel CPU architects, the company builds general-purpose compute IP aimed at eliminating CPU bottlenecks in latency-sensitive and agentic AI applications.

5 investors

Owkin develops AI Scientist, an autonomous AI system that uses biological large language models and multimodal patient data to accelerate drug discovery for pharmaceutical and biotech companies. The company aims to automate early-stage R&D and compress decades of discovery timelines into years.

5 investors

AI Clearing provides AI-powered construction intelligence using drone imagery analysis for contractors and asset owners, enabling volume calculations, progress tracking, and deviation detection on project sites.

5 investors

ai-coustics provides an audio reliability layer with speech technology such as Voice Focus, which removes background noise and other voices to improve transcription accuracy and keep voice agents responsive in noisy environments. It offers an SDK with real-time, low-latency inference for developers building voice applications across STT, TTS, and LLM stacks.

5 investors

AirMyne develops engineered carbon removal technology that captures CO2 directly from the air, as well as at point-of-emissions, to help corporations and governments manage and reduce their CO2 emissions. Its platform is designed for high uptime and durable, scalable carbon removal capacity.

5 investors